{"id":"W2974960379","doi":"10.1056/nejmoa1908681","title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":2346,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"National Institute for Health and Care Research; Boehringer Ingelheim","keywords":"Nintedanib; Idiopathic pulmonary fibrosis; Medicine; Lung; Fibrosis; Tyrosine-kinase inhibitor; Interstitial lung disease; Pathology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006852513408504109,"score_gpt":0.2727589832707856,"score_spread":0.2659064698622815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}